
<table style="text-align:center"><caption><strong>Newey-West Adjusted Poisson Models of Orphan Drug Market Authorizations</strong></caption>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="5"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="5" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="5">Annual Number of Orphan Drug Market Authorizations</td></tr>
<tr><td style="text-align:left"></td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td><td>Model 5</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">US (β<sup>̂</sup><sub>1</sub>)</td><td>1.396<sup>***</sup></td><td>1.090<sup>***</sup></td><td>0.669<sup>***</sup></td><td>0.730<sup>**</sup></td><td>0.955<sup>*</sup></td></tr>
<tr><td style="text-align:left"></td><td>(0.152)</td><td>(0.218)</td><td>(0.192)</td><td>(0.353)</td><td>(0.567)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004 (β<sup>̂</sup><sub>2</sub>)</td><td>0.110<sup>***</sup></td><td>0.077<sup>***</sup></td><td>0.057<sup>***</sup></td><td></td><td>0.037</td></tr>
<tr><td style="text-align:left"></td><td>(0.012)</td><td>(0.020)</td><td>(0.015)</td><td></td><td>(0.059)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD) (β<sup>̂</sup><sub>3</sub>)</td><td></td><td>0.012<sup>**</sup></td><td></td><td>0.044<sup>***</sup></td><td>0.017</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.005)</td><td></td><td>(0.012)</td><td>(0.045)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate Per Capita (β<sup>̂</sup><sub>4</sub>)</td><td></td><td>0.006</td><td>0.007</td><td>-0.001</td><td>0.007</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.013)</td><td>(0.011)</td><td>(0.011)</td><td>(0.011)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US (β<sup>̂</sup><sub>5</sub>)</td><td></td><td></td><td>0.067<sup>***</sup></td><td></td><td>0.094</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.015)</td><td></td><td>(0.066)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US (β<sup>̂</sup><sub>6</sub>)</td><td></td><td></td><td></td><td>-0.008</td><td>-0.019</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.010)</td><td>(0.044)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept (β<sup>̂</sup><sub>0</sub>)</td><td>1.288<sup>***</sup></td><td>1.303<sup>***</sup></td><td>1.834<sup>***</sup></td><td>1.258<sup>***</sup></td><td>1.588<sup>**</sup></td></tr>
<tr><td style="text-align:left"></td><td>(0.202)</td><td>(0.150)</td><td>(0.187)</td><td>(0.349)</td><td>(0.691)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">AIC</td><td>261</td><td>258</td><td>246</td><td>282</td><td>250</td></tr>
<tr><td style="text-align:left">RMSE</td><td>8.03</td><td>8.41</td><td>7.57</td><td>10.52</td><td>7.5</td></tr>
<tr><td style="text-align:left">Log Likelihood</td><td>-127.33</td><td>-123.9</td><td>-117.92</td><td>-135.95</td><td>-117.78</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="5" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
